Literature DB >> 6605963

Intracellular penetration and antimicrobial activity of antibiotics.

R F Jacobs, C B Wilson.   

Abstract

Delayed response or recurrence of clinical infections may, in part, be due to the inability of certain antibiotics to penetrate human polymorphonuclear leukocytes (PMN) and exert intracellular antibacterial activity. We determined the penetration of PMN by certain hydrophilic and certain lipophilic antibiotics, and assessed their activity against intracellular Haemophilus influenzae, type b or Staphylococcus aureus. We found that penicillin G was excluded from human PMN while chloramphenicol was concentrated within these cells; chloramphenicol killed significantly more intracellular H. influenzae than did penicillin or ampicillin. Clindamycin and trimethoprim penetrated into normal and chronic granulomatous disease (CGD) PMN equally and were at least transiently concentrated in the cells. Clindamycin and the combinations trimethoprim/sulphamethoxazole and trimethoprim/rifampicin were most effective in killing intracellular Staph. aureus in vitro; these antibiotics reduced the bacterial density in CGD PMN to values comparable to those in normal PMN. The mechanism by which clindamycin and rifampicin killed intracellular Staph. aureus appeared to be due to direct antimicrobial activity. Antibiotics that penetrate into phagocytes may be more effective in infections due to pathogens capable of intracellular survival.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605963     DOI: 10.1093/jac/12.suppl_c.13

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  18 in total

Review 1.  Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning.

Authors:  D E Nix; S D Goodwin; C A Peloquin; D L Rotella; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

Review 2.  Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.

Authors:  D E Nix; S D Goodwin; C A Peloquin; D L Rotella; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

3.  Efficacies of ofloxacin, rifampin, and clindamycin in treatment of Staphylococcus aureus abscesses and correlation with results of an in vitro assay of intracellular bacterial killing.

Authors:  D M Bamberger; B L Herndon; M Dew; R P Chern; H Mitchell; L E Summers; R F Marcus; S C Kim; P R Suvarna
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

4.  Penetration of brodimoprim into human neutrophils and intracellular activity.

Authors:  P C Braga; M Dal Sasso; S Maci; G Bondiolotti; E Fonti; S Reggio
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

5.  Intracellular accumulation of ofloxacin-loaded liposomes in human synovial fibroblasts.

Authors:  M Fresta; A Spadaro; G Cerniglia; I M Ropero; G Puglisi; P M Furneri
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

6.  In vivo potentiation of polymorphonuclear leukocyte chemotaxis by clindamycin.

Authors:  A T Skoutelis; P E Lianou; H P Bassaris
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

7.  Intracellular activity of tosufloxacin (T-3262) against Salmonella enteritidis and ability to penetrate into tissue culture cells of human origin.

Authors:  T Noumi; N Nishida; S Minami; Y Watanabe; T Yasuda
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

8.  Reduction of wall degradability of clindamycin-treated staphylococci within macrophages.

Authors:  J Wecke; L Johannsen; P Giesbrecht
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

9.  Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.

Authors:  A Saito; K Sawatari; Y Fukuda; M Nagasawa; H Koga; A Tomonaga; H Nakazato; K Fujita; Y Shigeno; Y Suzuyama
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

10.  Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.

Authors:  C S Goodwin; B J Marshall; E D Blincow; D H Wilson; S Blackbourn; M Phillips
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.